Siemens Healthineers AG (ETR: SHL)
Germany
· Delayed Price · Currency is EUR | Market Cap | 55.57B |
| Revenue (ttm) | 22.36B |
| Net Income (ttm) | 1.94B |
| Shares Out | 1.12B |
| EPS (ttm) | 1.73 |
| PE Ratio | 28.79 |
| Forward PE | 20.19 |
| Dividend | 0.95 (1.93%) |
| Ex-Dividend Date | n/a |
| Volume | 665,717 |
| Open | 49.12 |
| Previous Close | 49.13 |
| Day's Range | 49.12 - 49.95 |
| 52-Week Range | 47.31 - 58.14 |
| Beta | 0.70 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2024 |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and... [Read more]
Financial Performance
In 2024, Siemens Healthineers AG's revenue was 22.36 billion, an increase of 3.15% compared to the previous year's 21.68 billion. Earnings were 1.94 billion, an increase of 28.69%.
Financial StatementsNews
EQS-DD: Siemens Healthineers AG: Astrid Kristine Ploß, Sale of a portion of 989 Siemens Healthineers Shares to cover tax and contribution obligations on share transfers in connection with a ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 11.11.2024 / 19:52 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Astrid Kristine Ploß, Entitlement to transfer 989 Siemens Healthineers shares in connection with a Siemens Healthineers Share Program (transfer with value date ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 11.11.2024 / 19:46 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Sale of a portion of 7,171 Siemens Healthineers Shares to cover tax and contribution obligations on share transfers in connection ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 11.11.2024 / 19:40 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Entitlement to transfer 7,171 Siemens Healthineers shares in connection with Siemens Healthineers Share Programs (transfer with ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 11.11.2024 / 19:35 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Dr. Jochen Schmitz, Sale of a portion of 46,712 Siemens Healthineers Shares to cover tax and contribution obligations on share transfers in connection with a ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 11.11.2024 / 19:29 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Dr. Jochen Schmitz, Entitlement to transfer 46,712 Siemens Healthineers shares in connection with a Siemens Healthineers Share Program (transfer with value date ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 11.11.2024 / 19:23 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Dr. Bernhard Montag, Sale of 76,607 Siemens Healthineers Shares also partially to cover tax and contribution obligations in connection with a Siemens Healthineers ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 11.11.2024 / 19:17 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Dr. Bernhard Montag, Entitlement to transfer 76,607 Siemens Healthineers shares in connection with a Siemens Healthineers Share Program (transfer with value date ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 11.11.2024 / 19:11 CET/CEST The issuer is solely responsi...
Siemens Healthineers AG (SEMHF) Q4 2024 Earnings Call Transcript
Siemens Healthineers reports Q4 results
Siemens Healthineers meets full-year earnings forecast
German medical technology company Siemens Healthineers reported a full-year adjusted earnings before interest and taxes (EBIT) and revenue growth in line with analysts' consensus on Wednesday.
Siemens Healthineers: My Current Pick In Medtech Ahead Of Q4 2024
Patient Testing Set to be Overhauled with Automation from Siemens Healthineers that Tackles Lab Workflow and Staffing Challenges
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Siemens Healthineers now offers Atellica Integrated Automation on the Atellica CI Analyzer,1 to consolidate 25 tasks typically handled manually by clinical laboratory...
Siemens Healthineers to showcase their latest cross-disciplinary solutions
To overcome the worlds most threatening diseases at Global Health 2024
Siemens Healthineers cut to neutral by UBS, Chinese competition cited
Together with Siemens Healthineers, Varian Highlights Software and Imaging Innovations to Enable Personalized Patient Care at ASTRO 2024
PALO ALTO, Calif.--(BUSINESS WIRE)-- #ASTRO24--Together with Siemens Healthineers, Varian Highlights Software and Imaging Innovations to Enable Personalized Patient Care at ASTRO 2024.
Novartis' Cholesterol-Lowering Drug Shows Encouraging Outcome In Late-Stage Study
Wednesday, Novartis AG (NYSE: NVS) released topline results from twice-yearly Leqvio (inclisiran) in the Phase 3 V-MONO study, which met its primary endpoints. V-MONO is part of the 60,000-patient Vi...
Fertility-related stocks are becoming more attractive, Barclays says
CNBC's Silvia Amaro takes a look at why investors are growing more interested in fertility-related stocks.
Siemens Healthineers seeks €200M Novartis deal to boost cancer imaging business: FT
Siemens Healthineers (SEMHF) to acquire Novartis' (NVS) radioactive chemicals business for €200M, expanding its PET radiopharma presence. Read more here.
Siemens Healthineers seeks €200M Novartis deal to boost cancer imaging business: FT
Siemens Healthineers (SEMHF) to acquire Novartis' (NVS) radioactive chemicals business for €200M, expanding its PET radiopharma presence. Read more here.
Siemens Healthineers to buy Novartis unit for over $223 million, FT reports
Siemens Healthineers will pay more than 200 million euros ($223.8 million) to acquire the diagnostic arm of Advanced Accelerator Applications, owned by Novartis , the Financial Times reported on Satur...
Tech is core to curing disease
Healthcare systems have increasingly prioritized non-communicable diseases like cancer and diabetes. Siemens Healthineers is leveraging AI for personalized treatment plans, especially in areas with li...
EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Program-based order to sell a portion of 223 Siemens Healthineers shares to cover tax and contribution obligations on share ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 01.08.2024 / 21:46 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Entitlement to transfer 223 Siemens Healthineers shares in connection with a Siemens Healthineers Share Program (transfer with ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 01.08.2024 / 21:32 CET/CEST The issuer is solely responsi...
Siemens Healthineers sees return to growth in China in Q4, CFO says
Jochen Schmitz, CFO of Siemens Healthineers, discusses the German healthcare firm's latest round of earnings.